EuCornea - European Society of Cornea & Ocular Surface Disease Specialists

20/08/2026

New EuCornea Congress Content Now Available for Members

Want to revisit some of the key discussions from the 17th EuCornea Congress?

👁️ Content from the 2026 EuCornea Congress in Porto is now available in the EuCornea Members Area, with further educational content being added each month.

NEW FOR AUGUST
🎓 EuCornea 2026 Global Symposium
🎓 Instructional Course - A Novel Artificial Endothelial Lamellar for Treating High-Risk Endothelial Decompensation

EuCornea members can access exclusive congress content throughout the year, helping you keep up with the latest thinking, techniques and expert perspectives in cornea and ocular surface disease.

Not yet a member? Join the EuCornea community and unlock access.

🔹 Full Membership: €75
🔹 Trainee Membership: €45

👉 Join EuCornea: https://eucornea.org/eucornea-membership

19/08/2026

How are advances in corneal biomechanics shaping the surgical management of keratoconus?

A Touch Ophthalmology review by Emilio A. Torres-Netto, Mark Hillen and Farhad Hafezi explores the evolution of corneal allogenic intrastromal ring segments (CAIRS), including the development of ECO-CAIRS and its potential role in keratoconus management.

The authors also highlight areas where further research is needed, including long-term biomechanical effects and optimisation of treatment protocols.

Read the open-access article:
https://touchophthalmology.com/corneal-and-external-disorders/journal-articles/advancing-keratoconus-management-eco-cairs-biomechanics-and-the-evolution-of-corneal-allogenic-intrastromal-ring-segments/

11/08/2026

A Phase 3 clinical trial evaluating urcosimod for neuropathic corneal pain is moving forward following feedback from the US FDA.

The NEPTUNE trial is expected to enrol approximately 111 patients across the US and Europe.

Read more: https://www.ophthalmologytimes.com/view/okyo-pharma-outlines-path-to-phase-3-neptune-trial-of-urcosimod-for-neuropathic-corneal-pain

Via Ophthalmology Times

The trial will enroll approximately 111 patients across the US and Europe following positive FDA feedback from a Type D meeting

10/08/2026

One day. The latest thinking in corneal care.

Cornea Day at brings together leading experts from the ESCRS Cornea Committee and EuCornea to discuss the latest developments in corneal pathology, surgical innovation and evidence-based clinical practice.

📅 Friday, 11 September 2026
🕗 08:00–16:30 BST
📍 ExCeL London during the 44th Congress of the ESCRS

As sessions will not be recorded or available on demand, this is a programme best experienced in person.

Find out more and register:
https://pagv3.virtual-meeting.org/escrs/escrs2026/en-GB/pag/session/97709?guestPreview=1

Please note that Cornea Day requires a separate registration fee in addition to the main ESCRS Congress registration.

05/08/2026

Synthetic Corneal Implant Shows Promise in Chronic Corneal Oedema

A recent case series has reported encouraging outcomes using a synthetic corneal endothelial implant in patients with chronic corneal oedema, including eyes with previous failed endothelial keratoplasty.

Read more: https://www.ophthalmologytimes.com/view/synthetic-corneal-implant-shows-promise-in-eyes-with-chronic-corneal-oedema

Via Ophthalmology Times Europe

Real-world data support EndoArt as donor-independent option in high-risk patients

04/08/2026

Targeting Schwann Cells: A New Approach to Repairing Corneal Injury

New research from UConn Health explores a potential new approach to promoting corneal nerve repair by targeting Schwann cells. The findings may have implications for corneal injuries associated with dry eye disease, surgery and chemical exposure.

Read more: https://today.uconn.edu/2026/06/targeting-schwann-cells-a-new-approach-to-repairing-corneal-injury/

Via UConn Today - Original Article: Li, M., C. A. Tallo, M. K. Eddy, et al. 2026. “ DKK1 Targeting in Corneal Schwann Cells Rescues Axonal Regeneration and Mechanosensory Function After Corneal Injury.” Journal of Neuroscience Research 104, no. 6: e70142. https://doi.org/10.1002/jnr.70142 (OPEN ACCESS).

30/07/2026

📅 Cornea Day returns to

Join the ESCRS Cornea Committee and EuCornea on Friday, 11 September in London for a full day dedicated to the latest advances in corneal disease and surgery.

The programme will explore:
🔹 Corneal pathology
🔹 Surgical innovation
🔹 New clinical evidence
🔹 Practical approaches to modern corneal care

📍 ExCeL London
🕗 08:00–16:30 BST

⚠️ Please note: Cornea Day requires a separate registration from the main ESCRS Congress, and sessions will not be live streamed or available on-demand, making in-person attendance the only way to experience the programme.

🔗 https://pagv3.virtual-meeting.org/escrs/escrs2026/en-GB/pag/session/97709?guestPreview=1